Becton, Dickinson And Company share price today
(NASDAQ: BDX)

Name: Becton, Dickinson And Company Share Price Today (NASDAQ: BDX) - Becton, Dickinson And Company Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Becton, Dickinson And Company share price is $240.47 & ₹20,798.25 as on 24 Jan 2025, 2.30 'hrs' IST

$240.47

▲

2.55

(1.07%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Becton, Dickinson And Company share price in Dollar and Rupees. Guide to invest in Becton, Dickinson And Company stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Becton, Dickinson And Company, along with analyst recommendations, forecasts, and comprehensive financials.

Becton, Dickinson And Company share price movements

Today's Low: $237.36
Today's High: $240.85
$240.47
1.3%
Downside
Day's Volatility :1.45%
Upside
0.16%
52 Weeks Low: $218.75
52 Weeks High: $248.42
$240.47
9.03%
Downside
52 Weeks Volatility :11.94%
Upside
3.2%

Becton, Dickinson And Company Returns

Period	Becton, Dickinson And Company	Sector (Health Care)	Index (Russel 2000)
3 Months	-0.09%	-4.8%	0.0%
6 Months	0.26%	-5.1%	0.0%
1 Year	0.57%	2.5%	0.0%
3 Years	-7.82%	10.2%	-13.0%

Becton, Dickinson And Company Key Statistics

in dollars & INR

Previous Close	$237.92
Open	$238.48
Today's High	$240.85
Today's Low	$237.355
Market Capitalization	$69.0B
Today's Volume	$1.3M
52 Week High	$248.42
52 Week Low	$218.75
Revenue TTM	$19.8B
EBITDA	$5.1B
Earnings Per Share (EPS)	$5.85
PE Ratio	40.67
Dividend Yield	1.75%
Profit Margin	7.13%
Quarterly Earnings Growth YOY	2.9%
Return On Equity TTM	5.63%

How to invest in Becton, Dickinson And Company Stock (BDX) from India?

It is very easy for Indian residents to invest directly in Becton, Dickinson And Company from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Becton, Dickinson And Company stock in both Indian Rupees (INR) and US Dollars (USD). Search for Becton, Dickinson And Company or BDX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Becton, Dickinson And Company or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Becton, Dickinson And Company shares which would translate to 0.004 fractional shares of Becton, Dickinson And Company as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Becton, Dickinson And Company, in just a few clicks!

Returns in Becton, Dickinson And Company for Indian investors in Rupees

Investment Value

₹1,00,000

Becton, Dickinson And Company investment value today

Current value as on today

₹1,05,758

Returns

₹5,758

(+5.76%)

Returns from Becton, Dickinson And Company Stock

₹1,649 (+1.65%)

Dollar Returns

₹4,109 (+4.11%)

Indian investors sentiment towards Becton, Dickinson And Company

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Becton, Dickinson And Company on INDmoney from India has grown in the last 30 days as on Jan 24, 2025. 0% more investors are searching Becton, Dickinson And Company in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Becton, Dickinson And Company

Name	Shares Held	Change in Shares	% of Assets
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	435	0.00	0.53%
Motilal Oswal S&P 500 Index Fund Direct Growth	2493	-37.05	0.13%

Global Institutional Holdings in Becton, Dickinson And Company

Vanguard Group Inc
9.16%
BlackRock Inc
7.68%
State Street Corp
4.81%
T. Rowe Price Associates, Inc.
4.69%
Morgan Stanley - Brokerage Accounts
3.79%
T. Rowe Price Investment Management,Inc.
3.07%

Analyst Recommendation on Becton, Dickinson And Company

Buy

70%Buy

30%Hold

0%Sell

Based on 20 Wall street analysts offering stock ratings for Becton, Dickinson And Company(by analysts ranked 0 to 5 stars)

Based on 20 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Becton, Dickinson And Company

What analysts predicted

Upside of 15.05%

Target:

$276.67

Current:

$240.47

Insights on Becton, Dickinson And Company

Price Movement
In the last 1 month, BDX stock has moved up by 4.8%
Increasing Revenue
Becton, Dickinson And Company has shown positive revenue growth over the last two quarters. Their revenue increased from $4.99 billion to $5.43 billion, which represents an average increase of 8.2% each quarter.
Decreasing Net Profit
Becton, Dickinson And Company's net profit has been declining over the last three quarters. It decreased from $537.0 million to $421.0 million, which represents an average decrease of 11.4% each quarter.
BDX vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 65.0% return, outperforming this stock by 63.6%
BDX vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 124.4% return, outperforming this stock by 132.9%
Price to Sales
Becton, Dickinson And Company (BDX) has a Price-to-Sales Ratio of 3.5, meaning that investors are willing to pay $3.5 for every $1 of sales the company generates. In comparison, investors pay significantly more for Intuitive Surgical, Inc., costing $27.4 for every $1 of sales. This suggests that BDX is considered to be a more affordable option in terms of sales relative to its stock price.

Becton, Dickinson And Company Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$17.3B	↑ 8.18%
Net Income	$1.2B	↑ 292.28%
Net Profit Margin	7.06%	↑ 5.11%

	FY20	Y/Y Change
Revenue	$17.1B	↓ 1.0%
Net Income	$874.0M	↓ 28.36%
Net Profit Margin	5.11%	↓ 1.95%

	FY21	Y/Y Change
Revenue	$20.2B	↑ 18.29%
Net Income	$2.1B	↑ 139.36%
Net Profit Margin	10.33%	↑ 5.22%

	FY22	Y/Y Change
Revenue	$18.9B	↓ 6.81%
Net Income	$1.8B	↓ 14.96%
Net Profit Margin	9.43%	↓ 0.9%

	FY23	Y/Y Change
Revenue	$19.4B	↑ 2.66%
Net Income	$1.5B	↓ 16.58%
Net Profit Margin	7.66%	↓ 1.77%

	FY24	Y/Y Change
Revenue	$20.2B	↑ 4.16%
Net Income	$1.7B	↑ 14.89%
Net Profit Margin	8.45%	↑ 0.79%

	Q2 FY23	Q/Q Change
Revenue	$4.9B	↑ 1.18%
Net Income	$407.0M	↓ 11.52%
Net Profit Margin	8.34%	↓ 1.2%

	Q3 FY23	Q/Q Change
Revenue	$5.1B	↑ 4.28%
Net Income	$108.0M	↓ 73.46%
Net Profit Margin	2.12%	↓ 6.22%

	Q4 FY23	Q/Q Change
Revenue	$4.7B	↓ 7.49%
Net Income	$281.0M	↑ 160.19%
Net Profit Margin	5.97%	↑ 3.85%

	Q1 FY24	Q/Q Change
Revenue	$5.0B	↑ 7.2%
Net Income	$537.0M	↑ 91.1%
Net Profit Margin	10.64%	↑ 4.67%

	Q2 FY24	Q/Q Change
Revenue	$5.0B	↓ 1.09%
Net Income	$487.0M	↓ 9.31%
Net Profit Margin	9.76%	↓ 0.88%

	Q3 FY24	Q/Q Change
Revenue	$5.4B	↑ 8.96%
Net Income	$421.0M	↓ 13.55%
Net Profit Margin	7.74%	↓ 2.02%

	FY19	Y/Y Change
Profit	$8.3B	↑ 14.13%

	FY20	Y/Y Change
Profit	$7.6B	↓ 8.58%

	FY21	Y/Y Change
Profit	$9.4B	↑ 24.42%

	FY22	Y/Y Change
Profit	$8.5B	↓ 10.08%

	FY23	Y/Y Change
Profit	$8.2B	↓ 3.62%

	FY24	Y/Y Change
Profit	$9.1B	↑ 11.69%

	Q2 FY23	Q/Q Change
Profit	$2.1B	↓ 6.04%

	Q3 FY23	Q/Q Change
Profit	$1.7B	↓ 19.0%

	Q4 FY23	Q/Q Change
Profit	$2.0B	↑ 19.17%

	Q1 FY24	Q/Q Change
Profit	$2.3B	↑ 13.67%

	Q2 FY24	Q/Q Change
Profit	$2.3B	↑ 0.13%

	Q3 FY24	Q/Q Change
Profit	$2.5B	↑ 7.8%

	FY19	Y/Y Change
Operating Cash Flow	$3.3B	↑ 16.23%
Investing Cash Flow	$-741.0M	↓ 95.32%
Financing Cash Flow	$-3.2B	↑ 5556.14%

	FY20	Y/Y Change
Operating Cash Flow	$3.5B	↑ 6.28%
Investing Cash Flow	$-1.2B	↑ 66.26%
Financing Cash Flow	$22.0M	↓ 100.68%

	FY21	Y/Y Change
Operating Cash Flow	$4.6B	↑ 31.31%
Investing Cash Flow	$-1.9B	↑ 52.6%
Financing Cash Flow	$-3.3B	↓ 15127.27%

	FY22	Y/Y Change
Operating Cash Flow	$2.6B	↓ 43.34%
Investing Cash Flow	$-3.2B	↑ 71.28%
Financing Cash Flow	$-591.0M	↓ 82.12%

	FY23	Y/Y Change
Operating Cash Flow	$3.0B	↑ 13.52%
Investing Cash Flow	$-716.0M	↓ 77.76%
Financing Cash Flow	$-2.0B	↑ 231.13%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$1.1B	↑ 486.96%
Investing Cash Flow	$-329.0M	↑ 41.2%
Financing Cash Flow	$-1.8B	↓ 231.16%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$1.3B	↑ 22.69%
Investing Cash Flow	$-716.0M	↑ 117.63%
Financing Cash Flow	$-998.0M	↓ 44.34%

Becton, Dickinson And Company Technicals Summary

Sell

Neutral

Buy

Becton, Dickinson And Company is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Becton, Dickinson And Company Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Becton, Dickinson And Company	4.3%	0.26%	0.57%	-7.82%	-14.95%
Intuitive Surgical, Inc.	13.29%	38.33%	62.8%	131.11%	222.7%
Alcon Ag	2.87%	-4.92%	16.36%	19.6%	45.42%
West Pharmaceutical Services Inc	4.33%	22.16%	-1.79%	-8.06%	123.72%
Resmed Inc.	5.75%	25.52%	32.72%	6.53%	53.98%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Becton, Dickinson And Company	40.67	40.67	1.09	14.35	0.06	0.03	0.02	89.47
Intuitive Surgical, Inc.	97.13	97.13	4.38	6.92	0.16	0.08	NA	43.75
Alcon Ag	37.84	37.84	3.21	3.03	0.06	0.03	0.0	43.25
West Pharmaceutical Services Inc	51.22	51.22	6.28	6.63	0.18	0.1	0.0	37.96
Resmed Inc.	32.91	32.91	1.82	9.35	0.24	0.13	0.01	35.39

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Becton, Dickinson And Company	Buy	$69.0B	-14.95%	40.67	7.13%
Intuitive Surgical, Inc.	Buy	$215.2B	222.7%	97.13	28.51%
Alcon Ag	Buy	$44.2B	45.42%	37.84	11.89%
West Pharmaceutical Services Inc	Buy	$25.0B	123.72%	51.22	17.37%
Resmed Inc.	Buy	$36.4B	53.98%	32.91	23.15%

Becton, Dickinson And Company Dividend announcements

Becton, Dickinson And Company Dividends December, 2024
In the quarter ending December,2024. Becton, Dickinson And Company has declared dividend of $1.04
Read More

About Becton, Dickinson And Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Organization	Becton, Dickinson And Company
Employees	70000
CEO	Mr. Thomas E. Polen Jr.
Industry	Health Technology

Management People of Becton, Dickinson And Company

Name	Title
Mr. Thomas E. Polen Jr.	President, CEO & Chairman
Ms. Shana Carol Neal	Executive VP & Chief People Officer
Mr. Michael Garrison	Executive VP & President of Medical segment
Mr. Thomas J. Spoerel	Senior VP, Controller & Chief Accounting Officer
Ms. Elizabeth McCombs	Executive VP & Chief Technology Officer
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.	Senior VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board
Ms. Denise Russell Fleming	Executive VP of Technology & Global Services and Chief Information Officer
Mr. Greg Rodetis	Head of Investor Relations
Ms. Michelle Quinn	Executive VP & General Counsel
Claudia Curtis	Senior VP, Chief Ethics & Compliance Officer

Important FAQs about investing in Becton, Dickinson And Company (BDX) from India :

What is Becton, Dickinson And Company share price today?

Becton, Dickinson And Company share price today stands at $240.47, Open: $238.48 ; Previous Close: $237.92 ; High: $240.85 ; Low: $237.36 ; 52 Week High: $248.42 ; 52 Week Low: $218.75. The stock opens at $238.48, after a previous close of $237.92. The stock reached a daily high of $240.85 and a low of $237.36, with a 52-week high of $248.42 and a 52-week low of $218.75.

Can Indians buy Becton, Dickinson And Company shares?

Yes, Indians can invest in the Becton, Dickinson And Company (BDX) from India.

With INDmoney, you can buy Becton, Dickinson And Company at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Becton, Dickinson And Company at zero transaction cost.

How can I buy Becton, Dickinson And Company shares from India?

It is very easy to buy Becton, Dickinson And Company from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Becton, Dickinson And Company be purchased?

Yes, you can buy fractional shares of Becton, Dickinson And Company with INDmoney app.

What are the documents required to start investing in Becton, Dickinson And Company stocks?

To start investing in Becton, Dickinson And Company, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.